| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C0008976> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C0037793> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C0085421> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C0200345> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C0872152> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C0887920> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C0920472> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C1720825> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C5200696> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C5200697> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33414636_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Faculty of Pharmacy, Universitas Indonesia, Depok, West Java 16424, Indonesia.\', \'Functional Medical Staff of Surgical Oncology, Dharmais Cancer Hospital, Jakarta 11420, Indonesia.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Diptasaadya_Rasmina> <https://research.tib.eu/covid-19/entity/Harahap_Yahdiana> <https://research.tib.eu/covid-19/entity/Purwanto_Denni_Joko>
?:doi	<https://research.tib.eu/covid-19/entity/10.2147/DDDT.S278892>
?:doi	10.2147/DDDT.S278892
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Drug design, development and therapy
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33414636>
?:pmid	<https://research.tib.eu/covid-19/entity/33414636>
?:pmid	33414636
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.974
?:rankingScore_hIndex	40
?:title	Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33414636>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33414636>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all